In our published paper, there were two errors to be corrected as follows.
In line 11 of first paragraph in Discussion section, ''bolus insulin [15 units per day'' should be ''bolus insulin C15 units per day''. The last sentence of Discussion section should be ''In conclusion, add-on sitagliptin may be a new therapeutic option in patients with type 2 diabetes with inadequate glycemic control by insulin therapy, possibly using bolus insulin dose of over 15 units per day''.
The online version of the original article can be found under doi:10.1007/s13340-013-0155-6. 
